Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method

BACKGROUND: Immunohistochemistry (IHC)-based surrogate assay is the prevailing method in daily clinical practice to determine the necessity of chemotherapy for Luminal-like breast cancer patients worldwide. It relies on Ki67 scores to separate Luminal A-like from Luminal B-like breast cancer subtype...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Junmei, Lyu, Yan, Zou, Jiarui, Zhang, Yunyun, Xie, Shuishan, Jing, Lili, Tang, Fangrong, Lyu, Jiahong, Zhang, Wenfeng, Zhang, Jianbo, Wang, Xunting, Chen, Kuisheng, Zhang, Jiandi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485584/
https://www.ncbi.nlm.nih.gov/pubmed/34604077
http://dx.doi.org/10.3389/fonc.2021.737781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485584/
https://www.ncbi.nlm.nih.gov/pubmed/34604077
http://dx.doi.org/10.3389/fonc.2021.737781

Ejemplares similares